Clinical Trial Update: Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Nipent, Cytoxan, and Rituxan in lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• NIPENT (pentostatin)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-23